Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance

Autor:	Q.S. Huang, Michael G Baker, Marc-Alain Widdowson, Conroy Wong, Nicola Turner, Deborah A Williamson, Richard J. Webby
Rok vydání:	2015
Předmět:	Pulmonary and Respiratory Medicine medicine.medical_specialty Biomedical Research Epidemiology 030231 tropical medicine Population Review Article medicine.disease_cause disease burden immunology 03 medical and health sciences 0302 clinical medicine Influenza Human Pandemic medicine Influenza A virus Humans risk factors 030212 general & internal medicine Intensive care medicine education Disease burden education.field_of_study vaccine effectiveness business.industry Public health Public Health Environmental and Occupational Health 3. Good health Vaccination Infectious Diseases Vaccination policy Influenza Vaccines Population Surveillance Immunology Human mortality from H5N1 influenza business
Zdroj:	Influenza and Other Respiratory Viruses
ISSN:	1750-2659 1750-2640
DOI:	10.1111/irv.12315
Popis:	The 2009 influenza A(H1N1)pdm09 pandemic highlighted the need for improved scientific knowledge to support better pandemic preparedness and seasonal influenza control. The Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) project, a 5-year (2012–2016) multiagency and multidisciplinary collaboration, aimed to measure disease burden, epidemiology, aetiology, risk factors, immunology, effectiveness of vaccination and other prevention strategies for influenza and other respiratory infectious diseases of public health importance. Two active, prospective, population-based surveillance systems were established for monitoring influenza and other respiratory pathogens among those hospitalized patients with acute respiratory illness and those enrolled patients seeking consultations at sentinel general practices. In 2015, a sero-epidemiological study will use a sample of patients from the same practices. These data will provide a full picture of the disease burden and risk factors from asymptomatic infections to severe hospitalized disease and deaths and related economic burden. The results during the first 2 years (2012–2013) provided scientific evidence to (a) support a change to NZ's vaccination policy for young children due to high influenza hospitalizations in these children; (b) contribute to the revision of the World Health Organization's case definition for severe acute respiratory illness for global influenza surveillance; and (c) contribute in part to vaccine strain selection using vaccine effectiveness assessment in the prevention of influenza-related consultations and hospitalizations. In summary, SHIVERS provides valuable international platforms for supporting seasonal influenza control and pandemic preparedness, and responding to other emerging/endemic respiratory-related infections.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5838ffaed438750f63092b69621adafc https://doi.org/10.1111/irv.12315 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.